AbbVie Files for FDA Approval of Elagolix to Treat Endometriosis-associated Pain
News
AbbVie, in collaboration with Neurocrine Biosciences, has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for its lead candidate elagolix, formerly known as ABT-620, to treat women ... Read more